Mark Fellman

U.S. Food and Drug Administration, Silver Spring, MD

Mark Fellman, Branch Chief of the Cardiac Electrophysiology Devices Branch (CEDB) at the Food and Drug Administration and CEDB is responsible for premarket reviews of new marketing applications and investigational studies for cardiac ablation devices, diagnostic catheters, and advanced mapping systems. Mr. Fellman is a biomedical engineer, with 12 years of regulatory experience in therapeutic and diagnostic electrophysiology devices and clinical studies.